TK1 overexpression is associated with the poor outcomes of lung cancer patients: a systematic review and meta-analysis
- PMID: 29575921
- DOI: 10.2217/bmm-2017-0249
TK1 overexpression is associated with the poor outcomes of lung cancer patients: a systematic review and meta-analysis
Abstract
The study aimed to unveil the effect of TK1 expression on the clinicopathological significance and prognosis in patients with lung cancer. Results & methodology: Studies for meta-analysis were selected according to a thorough literature search in databases (PubMed, EMBASE and Chinese databases). Ten studies containing 1393 lung cancer patients were investigated in our analysis. The TK1 overexpression was associated with poorer overall survival(OS) in lung cancer patients (hazard ratio = 1.881; 95% CI:1.318-2.684, Z = 3.48; p = 0.001). Furthermore, The TK1 expression is associated with the clinicopathological features of lung cancer patients (tumor type, age, lymph node metastasis, distant metastasis and tumor, node, metastasis [TNM] stages). Discussion & conclusion: The TK1 expression might have a supportive implication in assessing biological behavior and prognosis of lung cancer patients.
Keywords: clinicopathological parameters; lung cancer; meta-analysis; prognosis; thymidine kinase 1.
Similar articles
-
Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.Tumour Biol. 2017 Jun;39(6):1010428317706479. doi: 10.1177/1010428317706479. Tumour Biol. 2017. PMID: 28651488
-
High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma.Tumour Biol. 2012 Apr;33(2):475-83. doi: 10.1007/s13277-011-0276-0. Epub 2011 Dec 6. Tumour Biol. 2012. PMID: 22143937
-
Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients.Respir Res. 2018 Aug 13;19(1):150. doi: 10.1186/s12931-018-0843-7. Respir Res. 2018. PMID: 30103737 Free PMC article.
-
Serum thymidine kinase 1 activity in the prognosis and monitoring of chemotherapy in lung cancer patients: a brief report.J Thorac Oncol. 2014 Oct;9(10):1568-72. doi: 10.1097/JTO.0000000000000276. J Thorac Oncol. 2014. PMID: 25521401
-
The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.Gene. 2019 Mar 20;689:76-83. doi: 10.1016/j.gene.2018.12.006. Epub 2018 Dec 12. Gene. 2019. PMID: 30552981 Review.
Cited by
-
The critical role of serum thymidine kinase 1(STK1) in predicting prognosis for immunotherapy in T4 stage lung squamous cell carcinoma.Heliyon. 2023 Feb 27;9(3):e14129. doi: 10.1016/j.heliyon.2023.e14129. eCollection 2023 Mar. Heliyon. 2023. PMID: 36938402 Free PMC article.
-
Thymidine Kinase 1 Expression Correlates with Tumor Aggressiveness and Metastatic Potential in OSCC.Diagnostics (Basel). 2025 Jun 19;15(12):1567. doi: 10.3390/diagnostics15121567. Diagnostics (Basel). 2025. PMID: 40564887 Free PMC article.
-
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.J Cancer Res Clin Oncol. 2023 Nov;149(15):14271-14282. doi: 10.1007/s00432-023-05089-z. Epub 2023 Aug 10. J Cancer Res Clin Oncol. 2023. PMID: 37561208 Free PMC article.
-
Thymidine kinase 1 indicates resistance to immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.Cell Oncol (Dordr). 2025 Jun;48(3):775-787. doi: 10.1007/s13402-025-01048-7. Epub 2025 Feb 26. Cell Oncol (Dordr). 2025. PMID: 40009128 Free PMC article.
-
High expression levels of pyrimidine metabolic rate-limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets.Purinergic Signal. 2020 Sep;16(3):347-366. doi: 10.1007/s11302-020-09711-4. Epub 2020 Jul 8. Purinergic Signal. 2020. PMID: 32638267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical